Is reliable in vivo detection of stem cell viability possible in a large animal model of myocardial injury?
Is reliable in vivo detection of stem cell viability possible in a large animal model of myocardial injury?
复制标题
在大型动物心肌损伤模型中是否可以可靠地体内检测干细胞活力?
DOI:
10.1161/circulationaha.112.119305
复制
发表时间:
2012
期刊:
影响因子:
37.8
通讯作者:
Yang,PhillipC
中科院分区:
文献类型:
--
作者:
Yang,PhillipC
In vivo cellular and molecular imaging of the stem cells has been developed to characterize the biological processes at the most fundamental level in an intact, living organism. With the emergence of cell-based therapy in a failing heart, the capability to evaluate engraftment and survival of the transplanted stem cells in vivo represents a critical measure of therapeutic efficacy. The stem cells at the very least must survive to restore the injured myocardium. 1, 2 Cell viability signal holds physiological relevance because it may correlate with the resultant myocardial restoration. There are 2 primary considerations for in vivo imaging of stem cell viability in the heart:(1) amplification of molecular and cellular signals and (2) high spatial and temporal resolution imaging of the myocardium. It is widely acknowledged that there is no single imaging modality that will fulfill all needs of in vivo stem cell imaging. However, an imaging modality that optimizes the technical objectives may extract meaningful information on cellular and molecular events of the transplanted cells. The predominant imaging modalities to assess stem cell survival in vivo in preclinical models consist of radionuclide imaging, optical imaging, and MRI. These modalities are commonly used in small animal models. Direct transfer of in vivo cellular and molecular imaging techniques from small to large animal models, however, has not been straightforward.